Price $22.77 |
Market Cap
774M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.45
|
P/S
2.28
|
Dividend %
-
|
|
P/CF
46.6
|
P/FCF
23.8
|
Op. Cash Flow
36.5K
|
FCF
0.8
|
|
Op. Margin
-1.50%
|
Net Margin
0.40%
|
ROE
0.30%
|
ROI
1.30%
|
|
ROA
0.20%
|
EPS Growth
104.70%
|
Current Ratio
2.2
|
Debt/Equity
17.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $173.42 | - | 1.90% | 51.13B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 12M | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.25 | - | 4.40% | 172.5M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
